RhumbLine Advisers’s Bicara Therapeutics Inc. Common Stock BCAX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$436K	Buy	46,911 +23,893	+104%	+$222K	﹤0.01%	2769
2025 Q1	$300K	Buy	23,018 +4,010	+21%	+$52.2K	﹤0.01%	2891
2024 Q4	$331K	Buy	+19,008	New	+$331K	﹤0.01%	2933